Status:
RECRUITING
Mothers and Babies Qatar (MB-Q): A Postpartum Depression Intervention
Lead Sponsor:
Sidra Medicine
Collaborating Sponsors:
Northwestern University
Conditions:
Postpartum Depression
Anxiety
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Qatar Mothers and Babies is a 4-year collaboration between Northwestern University Feinberg School of Medicine and Sidra Medicine in Doha, Qatar that will generate and evaluate a cultural and contextu...
Detailed Description
Postpartum depression and anxiety are the two most common perinatal mental health disorders (mental health disorders occurring during pregnancy and the year after birth), with prevalence rates higher ...
Eligibility Criteria
Inclusion
- Inclusion criteria are identical for the pilot study and RCT.
- Participants must be 18 years of age or older
- Participants should speak Arabic fluently
- Participants must be up to 28 + 0 weeks pregnant
- Participants should not be diagnosed with a fetal anomaly that is incompatible with life or whose anomalies will have significant physical or developmental morbidity
- Participants should not be currently receiving treatment for mental health difficulties,
- Participants should not have a history of a serious mental health condition and,
- Participants must screen between 6-12 on the Edinburgh Postpartum Depression Scale (EPDS) and/or 5-14 on the Generalized Anxiety and Depression Scale (GAD-7).
- Exclusion criteria:
- Participants who do not meet these screening criteria but are experiencing mild to moderate symptoms of depression will be provided mental health resources including a link to the Mothers \& Babies website with English and Arabic manuals for self-directed study.
- Screened women scoring \> 14 on the GAD-7 and/or \>12 on the EPDS and/or those currently receiving mental health treatment will be offered a referral to Sidra's Women's Mental Health Clinic for further evaluation and treatment, as needed.
- Anyone who endorses the suicidality question ideation (EPDS #10) will be offered same day review by a Sidra women's mental health clinician, who will ascertain the level of risk and offer assistance as clinically indicated.
Exclusion
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04442529
Start Date
May 1 2021
End Date
September 30 2024
Last Update
May 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sidra
Doha, Qatar, 26999